![Andy Bottomley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andy Bottomley
Directeur Financier/CFO chez
Fine & Rare Wines Ltd.
Profil
Andy Bottomley is currently the Chief Financial Officer & Director at Fine & Rare Wines Ltd. He previously worked as a Principal at Diageo Plc and as a Senior Venture Partner at Noetic Psychedelic.
Postes actifs de Andy Bottomley
| Sociétés | Poste | Début |
|---|---|---|
Fine & Rare Wines Ltd.
 Fine & Rare Wines Ltd. Specialty StoresRetail Trade Operates as an online platform for buying, selling fine wines and spirits | Directeur Financier/CFO | 01/05/2013 |
Anciens postes connus de Andy Bottomley
| Sociétés | Poste | Fin |
|---|---|---|
Noetic Psychedelic
 Noetic Psychedelic Investment ManagersFinance Noetic invests in companies located across the globe. The firm targets companies operating in the fields of across health sectors such as emerging technologies in molecular therapeutics/biotech, digital health, medical devices, and wellness. It provides financing for early stage capital requirements. | Private Equity Investor | - |
| DIAGEO PLC | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Diageo Plc
 Diageo Plc Beverages: AlcoholicConsumer Non-Durables Produces, distributes and sells wine, beer and other beverages | Consumer Non-Durables |
Fine & Rare Wines Ltd.
Fine & Rare Wines Ltd. Specialty StoresRetail Trade Operates as an online platform for buying, selling fine wines and spirits | Retail Trade |
Noetic Psychedelic
Noetic Psychedelic Investment ManagersFinance Noetic invests in companies located across the globe. The firm targets companies operating in the fields of across health sectors such as emerging technologies in molecular therapeutics/biotech, digital health, medical devices, and wellness. It provides financing for early stage capital requirements. | Finance |
Choisissez Zonebourse 
